Long-term With a Trifocal Intraocular Lens

Inclusion Criteria: * Phone call interview: * Patients of either sex, 45 years of age or older at the time of surgery and less than 80 years of age at the time of the phone call. * Patients implanted bilaterally with the AT LISA 839MP MIOL in the capsular bag. * No surgical complications reported in the clinical history that could affect postoperative visual acuity: damage to the capsular bag, intraocular hemorrhage, etc. * Operated between 66 months from the first implanted eye and up to 78 months from the surgery of the second eye * Patient able to hear, understand and give express consent orally. * Study visit: * To have participated in the first stage of the study corresponding to the phone call interview. * Irregular astigmatism in either eye measured with corneal tomography (total high-order corneal aberrations at 4 mm \< 0.5 μm). * Patient able to read, understand and provide a written informed consent form. * Sufficient availability, willingness, skills, and cognitive awareness to comply with follow-up/study procedures and study visits. Exclusion Criteria: * Phone call interview: * Any eye disease documented in the patient's clinical history that may potentially cause a loss of visual acuity or diplopia: Active or recurrent pathology of the anterior segment (chronic uveitis, iritis, iridocyclitis, rubeosis iridis, uncontrolled glaucoma, etc.), retinal or optic nerve pathologies such as diabetic retinopathy, macular degeneration, etc. * Eye surgery (including laser refractive surgery) performed before or after the operation with the intraocular lens. * Study Visit: * PCO ≥ 2 according to surgeon criteria that produces a loss of CDVA ≥ 0.2 logMAR * Any eye disorder that can potentially cause a loss of visual acuity or diplopia: Active or recurrent pathology of the anterior segment (chronic uveitis, iritis, iridocyclitis, rubeosis iridis, uncontrolled glaucoma, etc.), retinal or optic nerve pathologies such as diabetic retinopathy, macular degeneration, etc. * Eye surgery (including laser refractive surgery) performed before or after the operation with the intraocular lens. * Use of systemic or ocular medications that may affect vision in the last 6 months. * Subjects who participate in any clinical trial or research with drugs or medical devices within 30 days prior to entry into this research and/or during the period of participation in this research.